The US Food and Drug Administration, USFDA said on Tuesday, it was working with regulators in Mumbai to enhance the quality and safety of drugs as 40 per cent of generic drugs exported to America were from India. Margaret Hamburg, the visiting Commissioner of the US health regulator, termed India as a very important partner for her country in the pharma sector.Indian pharma companies have good growth potential, Hamburg said, adding if any company wants to become asignificant player in the international market it will have to pay attention to global standards. Hamburg asked the Indian health regulators to work closely with their foreign peers. As part of an enhancing mechanism across the world, the USFDA is strengthening its India operations by having 19 investigators from the present 12, she said. India is also 8th largest exporter of seafood and leading exporter of spices to the US.On food safety regulations, Hamburg said that we had very encouraging discussion with the Export Inspection Council and representative of food exporters. We have had a number of areas where we worked together to address food safety problems.We are preparing a framework for action and a number of collaborative activities like training and education.